ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 1121

$842K Total Retail Price of All Prescriptions

Rank: 127 out of 1121

762 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 762 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 17,388 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
AMLODIPINE BESYLATE 900 875 1 5
OMEPRAZOLE 844 784 2 6
LISINOPRIL 825 786 3 4
LEVOTHYROXINE SODIUM 788 764 4 2
HYDROCHLOROTHIAZIDE 761 735 5 10
ATENOLOL 693 673 6 16
SIMVASTATIN 670 640 7 1
PRAVASTATIN SODIUM 498 485 8 14
POTASSIUM CHLORIDE 493 476 9 12
METFORMIN HCL 437 422 10 8
LOSARTAN POTASSIUM 424 404 11 17
METOPROLOL TARTRATE 370 352 12 9
LOVASTATIN 335 315 13 26
DIOVAN 303 303 14 45
FUROSEMIDE 300 300 15 7
WARFARIN SODIUM 299 291 16 11
DONEPEZIL HCL 246 246 17 35
ATORVASTATIN CALCIUM 245 239 18 15
HYDROCODONE-ACETAMINOPHEN 234 216 S3 19 3
GLIMEPIRIDE 229 217 20 34
ENALAPRIL MALEATE 220 212 21 73
GABAPENTIN 212 206 22 13
ALENDRONATE SODIUM 202 202 23 37
KLOR-CON 8 193 193 24 212
CLOPIDOGREL 188 185 25 27
ISOSORBIDE MONONITRATE ER 176 176 26 62
NAMENDA 172 172 27 53
TRIAMTERENE-HCTZ 167 152 28 38
FOSINOPRIL SODIUM 163 163 29 233
SYNTHROID 162 157 30 55
TRAMADOL HCL 161 158 31 25
ALLOPURINOL 156 149 32 30
PAROXETINE HCL 154 146 33 58
PLAVIX 141 138 34 42
BENAZEPRIL HCL 133 120 35 41
METOPROLOL SUCCINATE 130 130 36 23
INSULIN SYRINGE 126 122 37 77
FELODIPINE ER 116 116 38 169
CITALOPRAM HBR 107 94 39 18
LIPITOR 103 103 40 106
PANTOPRAZOLE SODIUM 102 101 41 29
LOSARTAN-HYDROCHLOROTHIAZIDE 100 93 42 46
LANTUS 90 85 43 52
NIASPAN 85 85 44 166
CARVEDILOL 84 84 45 20
DILTIAZEM ER 82 81 46 105
PROAIR HFA 81 78 47 48
SPIRIVA 80 80 48 49
TAMSULOSIN HCL 78 76 49 32
CIPROFLOXACIN HCL 77 74 50 57
RAMIPRIL 75 75 51 74
CLONIDINE HCL 74 56 52 39
DIGOXIN 70 70 53 59
DOXYCYCLINE HYCLATE 69 67 54 103
PROPRANOLOL HCL 64 51 55 123
AGGRENOX 64 64 55 177
HUMALOG 63 63 57 150
NEXIUM 63 63 57 24
NITROSTAT 58 57 59 219
GEMFIBROZIL 56 56 60 88
DILTIAZEM 24HR CD 55 55 61 99
NYSTATIN 54 53 62 147
NADOLOL 53 53 63 285
FAMOTIDINE 51 51 64 63
DIOVAN HCT 51 51 64 90
LANTUS SOLOSTAR 50 50 66 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.